(Q51049722)

27 March 2018

title

The Merci Retrieval System for acute stroke: the Southeast Regional Stroke Center experience. (English)

1 reference

27 March 2018

author name string

T G Devlin

1

1 reference

27 March 2018

B W Baxter

2

1 reference

27 March 2018

T A Feintuch

3

1 reference

27 March 2018

N A Desbiens

4

1 reference

27 March 2018

publication date

1 January 2007

1 reference

27 March 2018

published in

Neurocritical Care

1 reference

27 March 2018

volume

6

1 reference

27 March 2018

issue

1

1 reference

27 March 2018

page(s)

11-21

1 reference

27 March 2018

https://scigraph.springernature.com/pub.10.1385/ncc:6:1:11

exact match

0 references

cites work

Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group

1 reference

12 December 2020

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

1 reference

12 December 2020

Tissue plasminogen activator for acute ischemic stroke

1 reference

12 December 2020

Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke

1 reference

12 December 2020

Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome

1 reference

12 December 2020

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

1 reference

12 December 2020

Editorial comment--degree of arterial recanalization: an end point for efficacy in future intravenous thrombolytic trials

1 reference

12 December 2020

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

12 December 2020

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial

1 reference

12 December 2020

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

12 December 2020

Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus

1 reference

12 December 2020

Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease

1 reference

12 December 2020

Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study

1 reference

12 December 2020

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

1 reference

12 December 2020

Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial

1 reference

12 December 2020

Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement.

1 reference

12 December 2020

New treatments in acute ischemic stroke

1 reference

12 December 2020

Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke

1 reference

12 December 2020

Methods and design considerations for randomized clinical trials evaluating surgical or endovascular treatments for cerebrovascular diseases

1 reference

12 December 2020

Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.

1 reference

12 December 2020

Identifiers

DOI

10.1385/NCC:6:1:11

1 reference

27 March 2018

Dimensions Publication ID

1008835751

0 references

1 reference

27 March 2018